Diseases in patients coming to a sleep center with symptoms related to restless legs syndrome

PLoS One. 2013 Aug 19;8(8):e71499. doi: 10.1371/journal.pone.0071499. eCollection 2013.

Abstract

Study objective: To explore the profile of patients who visit a sleep center with symptoms that fulfill the four essential criteria for restless legs syndrome (RLS).

Design: A prospective study.

Setting: Outpatients from one sleep disorders clinic in Taiwan.

Participants: 1,200 consecutive patients visit sleep disorders clinic with any sleep complaints.

Interventions: After completing a history and physical examination, all participants answered the RLS questionnaire. Subjects who fulfilled the four essential criteria for RLS were referred to a special clinic. A work-up including blood tests, polysomnography, and specialized neurological tests etc. was performed to make the final diagnosis.

Measurements and results: A total of 1,185 participants were enrolled, and, of these, 131(11.1%) fulfilled the four essential criteria for RLS, and 121 completed the supplemental work-up. Their mean age was 47.6±13.3 and 52.9% were male. Insomnia and snoring were the most common chief complaints. Obstructive sleep apnea syndrome and other diseases were found in 103 patients. Only 18 (14.9%) patients had no comorbid condition and were diagnosed with primary RLS.

Conclusions: Symptoms of RLS are common in patients with sleep complaints. Even in a sleep clinic, using a questionnaire approach for identification of RLS has a low positive predictive value. Clinicians should pay attention to the limitations of the 4-item questionnaire in diagnosis of RLS and also the importance of a careful differential diagnosis to identify possible secondary causes of RLS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Demography
  • Female
  • Health Facilities*
  • Humans
  • Male
  • Middle Aged
  • Restless Legs Syndrome / physiopathology*
  • Sleep / physiology*
  • Young Adult

Grants and funding

This study was supported by the Department of Industrial Technology of the Ministry of Economic Affairs, R.O.C. (100-EC-17-A-19-S1-163), National Science Council (NSC 101-2325-B-182 -012). Chang Gung Medical Foundation supports the funding for language editing this manuscript (CMRPG391251). This study is also partly sponsored by GlaxoSmithKline (XMRPG380121). The GlaxoSmithKline company sponsored man power of a research assistant for 6 months which cost around 8,000 USD. However, they have no role in study design and conduct, collection, analysis, and interpretation of the data, or writing or approval of the manuscript.